Bactericidal potential of drugs targeting the mevalonate pathway

被引：0
|
作者：
Weber, L. [1 ]
Hagemann, A. [1 ]
Jebens, H. [1 ]
Besser, M. [2 ]
Schlobach, J. [2 ]
Rockenfeller, P. [3 ]
Ehrhardt, A. [4 ]
Stuermer, E. [2 ,5 ]
Bachmann, H. S. [1 ]
机构：
[1] Witten Herdecke Univ, Inst Pharmacol & Toxicol, Ctr Biomed Educ & Res ZBAF, Sch Med,Fac Hlth, Witten, Germany
[2] Witten Herdecke Univ, Translat Wound Res, Ctr Biomed Educ & Res ZBAF, Sch Med,Fac Hlth, Witten, Germany
[3] Witten Herdecke Univ, Inst Biochem & Mol Med, Ctr Biomed Educ & Res ZBAF, Sch Med,Fac Hlth, Witten, Germany
[4] Witten Herdecke Univ, Inst Virol & Microbiol, Ctr Biomed Educ & Res ZBAF, Sch Med,Fac Hlth, Witten, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Dept Vasc Med, Univ Heart Ctr, Translat Wound Res, Hamburg, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2023年 / 396卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P007
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [21] Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions
    Laka, Kagiso
    Makgoo, Lilian
    Mbita, Zukile
    FRONTIERS IN GENETICS, 2022, 13
  • [22] Strategies to enhance epidermal growth factor inhibition: Targeting the mevalonate pathway
    Dimitroulakos, Jim
    Lorimer, Ian A.
    Goss, Glenwood
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4426S - 4431S
  • [23] Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor
    Mantha, AJ
    Hanson, JEL
    Goss, G
    Lagarde, AE
    Lorimer, IA
    Dimitroulakos, J
    CLINICAL CANCER RESEARCH, 2005, 11 (06) : 2398 - 2407
  • [24] Pharmacological inhibition of the mevalonate pathway increases the antitumor efficacy of anticancer drugs
    Nilsson, S.
    Huelsenbeck, J.
    Fritz, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2010, 381 : 43 - 43
  • [25] Selenoproteins, cholesterol-lowering drugs, and the consequences - Revisiting of the mevalonate pathway
    Moosmann, B
    Behl, C
    TRENDS IN CARDIOVASCULAR MEDICINE, 2004, 14 (07) : 273 - 281
  • [26] Targeting the mevalonate pathway, a novel anti-ferroptosis pathway, in hepatocellular carcinoma (HCC) treatment
    Chen, Yiling
    Lee, Derek
    Zhang, Misty Shuo
    Cheu, Jacinth Wing-Sum
    Wong, Carmen Chak-Lui
    CANCER RESEARCH, 2023, 83 (07)
  • [27] Potential mevalonate pathway precursors for enhanced production of gymnemic acid
    Zimare, Saurabha B.
    Malpathak, Nutan P.
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2020, 58 (09) : 651 - 655
  • [28] Inhibitors of the mevalonate pathway as potential therapeutic agents in multiple myeloma
    Baulch-Brown, Cindy
    Molloy, Timothy J.
    Yeh, Sung Lin
    Ma, David
    Spencer, Andrew
    LEUKEMIA RESEARCH, 2007, 31 (03) : 341 - 352
  • [29] Targeting the metabolic mevalonate pathway with statins as anti-breast cancer agents
    van Leeuwen, Jenna
    Pandyra, Aleksandra
    Goard, Carolyn
    Mullen, Peter J.
    Yu, Rosemary
    Penn, Linda Z.
    CANCER RESEARCH, 2017, 77
  • [30] Targeting the mevalonate pathway enhances the efficacy of 5-fluorouracil by regulating pyroptosis
    Xing, Zongrui
    Ma, Yong
    Jiang, Xiangyan
    Qing, Huiguo
    Wu, Yuxia
    Che, Shengfu
    Gao, Zhongti
    Wang, Keshen
    Wang, Tao
    He, Qichen
    Li, Zhigang
    Zhao, Bin
    Liu, Wenbo
    Sun, Haonan
    Yu, Zeyuan
    MEDICAL ONCOLOGY, 2024, 42 (01)
12345